Results 161 to 170 of about 26,442 (182)

Efficacy and Safety of Gefapixant, a P2X3 Receptor Antagonist, in Refractory Chronic Cough and Unexplained Chronic Cough (COUGH-1 and COUGH-2): Results From Two Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, Phase 3 Trials

Lancet, The, 2022
Jaclyn A. Smith, Ian D. Pavord, Alyn H Morice   +2 more
exaly  

Cough Desensitization Treatment: A Randomized, Sham-Controlled Pilot Trial for Patients With Refractory Chronic Cough

Respiratory Medicine, 2022
Laurie Slovarp, Paige Morkrid
exaly  

Chronic Refractory Cough: Objective Improvement With Aerodynamic-Focused

Journal of Voice, 2021
Priya Krishna, Thomas Murry, Brianna K Crawley   +2 more
exaly  

ATP, an Attractive Target for the Treatment of Refractory Chronic Cough

Purinergic Signalling, 2022
Alyn H Morice, Mengru Zhang
exaly  

REFRACTORY COUGH AND WHEEZING AFTER A SANDSTORM

CHEST, 2023
BAHARAN ZARRABIAN, SUMERA R AHMAD
openaire   +1 more source

Structural and Functional Correlates of Higher Cortical Brain Regions in Chronic Refractory Cough

Chest, 2022
Jin An, You Sook Cho, Yong Hwan Kim
exaly  

Unexplained or Refractory Chronic Cough in Adults

New England Journal of Medicine
Richard S, Irwin, J Mark, Madison
openaire   +2 more sources

Gefapixant for Refractory or Unexplained Chronic Cough?

JAMA, 2023
Richard S, Irwin, J Mark, Madison
openaire   +2 more sources

Gabapentin for Refractory Chronic Cough: A Randomised, Double-Blind, Placebo-Controlled Trial

Lancet, The, 2012
Peter G Gibson, Nicole M Ryan, Surinder S Birring   +2 more
exaly  

The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1)

Chest, 2020
Andrew Wood, Jaclyn A. Smith, Robert C. Miller   +2 more
exaly